Psychedelics in Medicine the History and Science and the Risks

Send us Fan MailMel interviews Karina Sergi, MS, MFT Director, Psychedelic Therapy Training; Director, Diversity, Equity & Inclusion and  Keith Heinzerling, MD Director, Treatment & Research In Psychedelics (TRIP) Center; Addiction Medicine.We discuss psychedelic associated therapy, ketamine, DMT, Psilocybin,  Hallucinogen persisting perception disorder (HPPD, Ontological shock, Psychnaughts and so much more as we continue our series on mental health treatment optionsThe Treatment and Research in Psychedelics clinic (TRIP) located at Pacific Neuroscience Institute. Their website: https://www.pacificneuroscienceinstitute.org/treatment-research-in-psychedelics/Support the show